SEC Form 4 · accession 0001127602-19-010077

INSULET CORP · PODD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Secretary and GC

Period of report

Mar 1, 2019

Accepted (ET)

Mar 5, 2019 · 7:15 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001145197

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Mar 1, 2019	M	16,639	$30.98	A	47,072	D
Common Stock^F1	Mar 1, 2019	M	1,166	$29.26	A	48,238	D
Common Stock^F1	Mar 1, 2019	M	1,422	$46.22	A	49,660	D
Common Stock^F1	Mar 1, 2019	M	1,748	$74.50	A	51,408	D
Common Stock^F2,F1	Mar 1, 2019	S	20,975	$94.6536	D	30,433	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F3	$30.98	Mar 1, 2019	M	16,639	D	—	Jun 29, 2025	Common Stock	16,639	11,093	D
Employee Stock Option (Right to Buy)^F4	$29.26	Mar 1, 2019	M	1,166	D	—	Feb 24, 2026	Common Stock	1,166	5,831	D
Employee Stock Option (Right to Buy)^F4	$46.22	Mar 1, 2019	M	1,422	D	—	Feb 22, 2027	Common Stock	1,422	5,686	D
Employee Stock Option (Right to Buy)^F4	$74.50	Mar 1, 2019	M	1,748	D	—	Feb 14, 2028	Common Stock	1,748	5,247	D

F1Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
F2The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $94.37 to $94.99. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
F4This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.